Press Room

Share

Oregon House Approves Senate Bill 1527, Cervical Cancer Screening Legislation Awaits Only Governor’s Signature

American Cancer Society Cancer Action Network Volunteer Advocates Laud Bill That Would Remove Cost Barriers to Supplemental Cancer Screenings for Those on State-Regulated Insurance

February 25, 2026

SALEM, Oregon -- Oregon will be the first state in the nation to eliminate out-of-pocket costs for supplemental cervical cancer screenings for residents on state-regulated insurance plans following House passage of Senate Bill 1527 on Tuesday. The vote followed unanimous approval in the Senate and awaits only Gov. Tina Kotek’s signature to become law.

“This legislation will clear the way for patients to get the procedures they need to identify and treat cancer as quickly as possible,” American Cancer Society Cancer Action Network Oregon Government Relations Director Jane Leo said. “We are grateful that lawmakers took the time to listen and learn the impact they could have to reduce the cancer burden for Oregonians during this session. We look forward to other states following their lead.”
 
For the roughly 5 percent of cervical screenings with abnormal results, a follow-up procedure is necessary to determine the presence of pre-cancer or cancer cells. Patients are covered fully for the initial screen, but out-of-pocket cost for the additional procedures lead some to go without, resulting in a higher risk of being diagnosed with late-stage cancer. The cost of a follow-up procedure, on average, is $700 to more than $1,000, even for commercially insured patients. The legislation does not eliminate out-of-pocket costs for treatment, only diagnostic testing, but presents a significant opportunity to assure income level does not dictate a patient’s ability to detect cancer early.

More Press Releases AboutBreast and Cervical Cancer, Access to Health Care, Remove Hurdles to Cancer Care, Oregon

Media Contacts

Shawn O'Neal
Senior Regional Media Advocacy Manager
[email protected]
208-596-1314

Related Press Releases

February 12, 2026

Legislation Improving Prescription Drug Access Advances Days Before Crossover

With crossover day looming, survivor advocates with the American Cancer Society Cancer Action Network (ACS CAN) are celebrating the passage of Senate Bill 161/House Bill 625 in their respective chambers. The same advocates gathered at the General Assembly earlier this month for ACS CAN’s annual Cancer Action Day to push for the legislation that would require insurers to offer flat-dollar copay-only plans instead of relying solely on coinsurance, which forces patients to pay a percentage of their medication’s cost. If signed by Governor Spanberger, more Virginians will gain more options and encounter fewer surprises when it comes to the cost of their care.  

Read More
February 11, 2026

Mississippi Senate Passes Biomarker Testing Coverage Bill

JACKSON, Miss. – The Mississippi Senate passed Senate Bill 2694 Wednesday, February 11, paving the way for increased access to biomarker testing for patients across the Magnolia State.

Read more
February 3, 2026

Advocates to Lawmakers: Improve Access to Cancer Care

As lawmakers dive into the 2026 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes. 

Read more